Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.88 DKK
−38.21 M DKK
0.00 DKK
6.25 M
About CURASIGHT A/S
Sector
Industry
CEO
Ulrich A. Krasilnikoff
Website
Headquarters
Copenhagen
Founded
2013
ISIN
DK0061295797
FIGI
BBG00X3GLSW8
Curasight A/S is a clinical development company. It engages in the business of exploiting a novel theragnostic platform with positron emissions tomography imaging and radionuclide therapy targeting the urokinase-type plasminogen activator receptor. The company was founded by Morten Persson, Andreas Kjær, Carsten Haagen Nielsen, and Jacob Madsen in 2013 and is headquartered in Copenhagen, Denmark.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of CURAS is 5.38 DKK — it has increased by 15.45% in the past 24 hours. Watch CURASIGHT A/S stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange CURASIGHT A/S stocks are traded under the ticker CURAS.
CURAS stock has fallen by −6.27% compared to the previous week, the month change is a −38.72% fall, over the last year CURASIGHT A/S has showed a −46.73% decrease.
CURAS reached its all-time high on Jan 25, 2021 with the price of 44.06 DKK, and its all-time low was 4.66 DKK and was reached on Apr 16, 2025. View more price dynamics on CURAS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CURAS stock is 15.67% volatile and has beta coefficient of −0.039. Track CURASIGHT A/S stock price on the chart and check out the list of the most volatile stocks — is CURASIGHT A/S there?
Today CURASIGHT A/S has the market capitalization of 98.55 M, it has decreased by −17.59% over the last week.
Yes, you can track CURASIGHT A/S financials in yearly and quarterly reports right on TradingView.
CURASIGHT A/S is going to release the next earnings report on May 28, 2025. Keep track of upcoming events with our Earnings Calendar.
CURAS net income for the last quarter is −12.33 M DKK, while the quarter before that showed −7.15 M DKK of net income which accounts for −72.55% change. Track more CURASIGHT A/S financial stats to get the full picture.
No, CURAS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CURAS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CURASIGHT A/S stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CURASIGHT A/S technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CURASIGHT A/S stock shows the sell signal. See more of CURASIGHT A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.